Samyang Corporation is the parent company of Samyang Group. Samyang Corporation is engaged in pharmaceutical business through its Pharmaceuticals Business Unit. Samyang Corporation has established its unique position in the pharmaceutical industry as a company specialized in the drug delivery systems, developing advanced drug delivery systems and medical devices using in-depth experiences in polymer chemistry and collaborative relationships with companies in Korea and US.
During the time, Samyang Corporation Success has secured several kinds of platform technologies for DDS in oral, transdermal, parenteral delivery area.
In oral delivery area, Samyang Corporation has established its proprietary orally disintegrating tablet technology and colon-specific delivery technology which is applicable to various kinds of drugs in conventional manufacturing facility for oral formulation.
Samyang Corporation has also accumulated its know-how and proprietary technologies in transdermal delivery area as one of the best manufacturer for transdermal products in Korea.
Parenteral delivery area is based on the biocompatible polymer technology which is applied for the solubilization of insoluble drugs and sustained delivery of injectables.
Samyang has commercialized anti-inflammation transdermal patch (Diclofenac plaster), patches for smoking cessation (Nicotine patch), paclitaxel formulations and so on. Samyang Corporation owns KGMP-approved morden manufacturing plant for transdermals and medical devices and Samyang Genex (subsidiary company of Samyang) also owns oncology injectable manufacturing plant as well as oncology API manufacturing plant.
The combination of drug delivery technology and manufacturing expertise is the key strength of Samyang Corporation.
The preferred partner for Samyang is a company who would like to license Samyang's products and technologies and develop further in its respective territories of interest. However, Samyang Corporation is open to any kinds of partnering strategy including co-development of specific products, contract manufacturing of transdermal products, and so on.
Mr. Hyungjin Jung
Senior Manager
Overseas Business Team